RxDoctor Payments Data

Craig Lampe, MD

Anesthesiology · Lubbock, TXNPI 1508807900

Payments from drug & device makers

What this record shows

This record is dominated by speaking fees: $42,982 of the $70,595 with a category attached, or 60.9%. Merck accounts for 98.9% of it on its own, with 6 other manufacturers making up the rest. Reporting peaked in 2019 at $61,669 and has fallen 99.9% since, to $58 in 2025. Among anesthesiology clinicians in TX with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$70,595in general payments, 2019–2025

Across 139 payments — averaging $507.88 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Merck$70K
  • Acacia Pharma Inc$276
  • Pacira Pharmaceuticals Incorporated$197
  • Chiesi USA, Inc.$126
  • Heron Therapeutics, Inc.$123
  • Medtronic$20
  • plus $19 from 1 others

What the payments were for

  • Speaking & faculty fees$42,98261%
  • Travel & lodging$24,72635%
  • Food & beverage$2,7834%
  • Education$1040%

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$70,595 in reported general payments places this provider in the 95th percentile of 3,899 anesthesiology providers in Texas.

See all anesthesiology providers in Texas

Medicare billing

Part B allowed, 2024
$2,657
Medicare patients
11
Services billed
11

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Other anesthesiology in Lubbock

See the full list for Texas

Where these figures come from

Is this you, or does something look wrong? →